Abstract
MicroRNAs (miRNAs) are small non-coding RNA regulators of protein synthesis that are essential for normal brain development and function. Their profiles are significantly altered in neurodegenerative diseases such as Alzheimer’s disease (AD) that is characterized by amyloid-β (Aβ) and tau deposition in brain. How deregulated miRNAs contribute to AD is not understood, as their dysfunction could be both a cause and a consequence of disease. To address this question we had previously profiled miRNAs in models of AD. This identified miR-9 and -181c as being down-regulated by Aβ in hippocampal cultures. Interestingly, there was a remarkable overlap with those miRNAs that are deregulated in Aβ-depositing APP23 transgenic mice and in human AD tissue. While the Aβ precursor protein APP itself is a target of miRNA regulation, the challenge resides in identifying further targets. Here, we expand the repertoire of miRNA target genes by identifying the 3′ untranslated regions (3′ UTRs) of TGFBI, TRIM2, SIRT1 and BTBD3 as being repressed by miR-9 and -181c, either alone or in combination. Taken together, our study identifies putative target genes of miRNAs miR-9 and 181c, which may function in brain homeostasis and disease pathogenesis.
Similar content being viewed by others
References
Baek D, Villen J, Shin C, Camargo FD et al (2008) The impact of microRNAs on protein output. Nature 455:64–71
Balastik M, Ferraguti F, Pires-da Silva A, Lee TH et al (2008) Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration. Proc Natl Acad Sci U S A 105:12016–12021
Baur JA, Pearson KJ, Price NL, Jamieson HA et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342
Beilharz TH, Humphreys DT, Clancy JL, Thermann R et al (2009) microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS ONE 4:e6783
Boissonneault V, Plante I, Rivest S, Provost P (2009) MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284:1971–1981
Clancy JL, Nousch M, Humphreys DT, Westman BJ et al (2007) Methods to analyze microRNA-mediated control of mRNA translation. Methods Enzymol 431:83–111
Cogswell JP, Ward J, Taylor IA, Waters M et al (2008) Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14:27–41
Cole AR, Noble W, van Aalten L, Plattner F et al (2007) Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer’s disease progression. J Neurochem 103:1132–1144
da Cruz e Silva OA, Henriques AG, Domingues SC, da Cruz e Silva EF (2010) Wnt signalling is a relevant pathway contributing to amyloid beta-peptide-mediated neuropathology in Alzheimer’s disease. CNS Neurol Disord Drug Targets 9:720–726
Damgaard T, Knudsen LM, Dahl IM, Gimsing P et al (2009) Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma. Leuk Lymphoma 50:236–246
David D, Hoerndli F, Gotz J (2005) Functional genomics meets neurodegenerative disorders: Part I. Transcriptomic and proteomic technology. Prog Neurobiol 76:153–168
Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379
Gotz J, Ittner LM, Fandrich M, Schonrock N (2008a) Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods? J Alzheimers Dis 14:423–429
Gotz J, Ittner LM, Schonrock N, Cappai R (2008b) An update on the toxicity of Abeta in Alzheimer’s disease. Neuropsychiatr Dis Treat 4:1033–1042
Haramati S, Chapnik E, Sztainberg Y, Eilam R et al (2010) miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107:13111–13116
Hebert SS, De Strooper B (2009) Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 32:199–206
Hebert SS, Horre K, Nicolai L, Papadopoulou AS et al (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 105:6415–6420
Hebert SS, Horre K, Nicolai L, Bergmans B et al (2009) MicroRNA regulation of Alzheimer’s Amyloid precursor protein expression. Neurobiol Dis 33:422–428
Hoerndli FJ, Toigo M, Schild A, Gotz J et al (2004) Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. Anal Biochem 335:30–41
Hoerndli F, David D, Gotz J (2005) Functional genomics meets neurodegenerative disorders: Part II. Application and data integration. Prog Neurobiol 76:169–188
Humphreys DT, Westman BJ, Martin DI, Preiss T (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 102:16961–16966
Hutchison ER, Okun E, Mattson MP (2009) The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair. Neuromol Med 11:153–161
Ittner LM, Ke YD, Delerue F, Bi M et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142:387–397
Kurosinski P, Gotz J (2002) Glial cells under physiologic and pathological conditions. Arch Neurol 59:1524–1528
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109–1122
Landgraf P, Rusu M, Sheridan R, Sewer A et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401–1414
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20
Lim Y-A, Rhein V, Baysang G, Meier F et al (2010) Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 10:1621–1633
Lin B, Madan A, Yoon JG, Fang X et al (2010) Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS ONE 5:e10210
Ma C, Rong Y, Radiloff DR, Datto MB et al (2008) Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev 22:308–321
Nelson PT, Wang WX (2010) MiR-107 is reduced in Alzheimer’s disease brain neocortex: validation study. J Alzheimers Dis 21:75–79
Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE et al (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer’s disease cortex reveals altered miRNA regulation. PLoS ONE 5:e8898
Ohkawa N, Kokura K, Matsu-Ura T, Obinata T et al (2001) Molecular cloning and characterization of neural activity-related RING finger protein (NARF): a new member of the RBCC family is a candidate for the partner of myosin V. J Neurochem 78:75–87
Ono K, Condron MM, Teplow DB (2009) Structure–neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A 106:14745–14750
Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat Neurosci 13:812–818
Qin W, Yang T, Ho L, Zhao Z et al (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281:21745–21754
Rane S, He M, Sayed D, Vashistha H et al (2009) Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104:879–886
Salminen A, Kaarniranta K (2009) SIRT1: regulation of longevity via autophagy. Cell Signal 21:1356–1360
Saunders LR, Sharma AD, Tawney J, Nakagawa M et al (2010) miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany, NY) 2:415–431
Schild A, Schmidt K, Lim YA, Ke Y et al (2006) Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation. Int J Dev Neurosci 24:437–443
Schonrock N, Ke YD, Humphreys D, Staufenbiel M et al (2010) Neuronal microRNA deregulation in response to Alzheimer’s disease amyloid-beta. PLoS ONE 5:e11070
Selbach M, Schwanhausser B, Thierfelder N, Fang Z et al (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455:58–63
Selkoe DJ, Podlisny MB (2002) Deciphering the genetic basis of Alzheimer’s disease. Annu Rev Genomics Hum Genet 3:67–99
Siomi H, Siomi MC (2010) Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38:323–332
Sud A, Del Bono EA, Haines JL, Wiggs JL (2008) Fine mapping of the GLC1K juvenile primary open-angle glaucoma locus and exclusion of candidate genes. Mol Vis 14:1319–1326
Tesseur I, Zou K, Esposito L, Bard F et al (2006) Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J Clin Invest 116:3060–3069
Tomiyama T, Matsuyama S, Iso H, Umeda T et al (2010) A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci 30:4845–4856
Vilardo E, Barbato C, Ciotti M, Cogoni C et al (2010) MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285:18344–18351
Wang WX, Rajeev BW, Stromberg AJ, Ren N et al (2008) The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213–1223
Wang WX, Wilfred BR, Madathil SK, Tang G et al (2010) miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 177:334–345
Wilquet V, De Strooper B (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 14:582–588
Wu C, Xu B, Yuan P, Ott J et al (2010) Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer. Pharmacogenet Genomics 20:389–395
Yamakuchi M, Ferlito M, Lowenstein CJ (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 105:13421–13426
Acknowledgements
This work is supported by grants from the Victor Chang Cardiac Research Institute (DH, TP), the National Health & Medical Research Council (JG, TP), the Australian Research Council (JG, TP), and the J.O. & J.R. Wicking Trust (JG). Postgraduate scholarship support for the laboratory of JG has been provided by the Wenkart Foundation and by Alzheimer’s Australia. NS is supported by the Human Frontier Science Program (HFSP).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schonrock, N., Humphreys, D.T., Preiss, T. et al. Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β. J Mol Neurosci 46, 324–335 (2012). https://doi.org/10.1007/s12031-011-9587-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-011-9587-2